{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:26Z","timestamp":1786993646159,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.leukres.2023.107351","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T18:55:17Z","timestamp":1689188117000},"page":"107351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia"],"prefix":"10.1016","volume":"132","author":[{"given":"Maximilian","family":"Stahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-5526","authenticated-orcid":false,"given":"Gerard","family":"Giblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-8245","authenticated-orcid":false,"given":"Eric S.","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline S.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-215X","authenticated-orcid":false,"given":"Evan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Wadleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Coleman","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-9652","authenticated-orcid":false,"given":"Shai","family":"Shimony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Copson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"DeAngelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Nohria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlise R.","family":"Luskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.leukres.2023.107351_bib1","first-page":"485","article-title":"Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia","volume":"57","author":"Yates","year":"1973","journal-title":"Cancer Chemother. Rep."},{"issue":"26","key":"10.1016\/j.leukres.2023.107351_bib2","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","article-title":"CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia","volume":"36","author":"Lancet","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2023.107351_bib3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/bloodadvances.2019000955","article-title":"Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper","volume":"4","author":"Neuendorff","year":"2020","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.leukres.2023.107351_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: The task force for cancer treatments and cardiovascular toxicity of the European society of cardiology (ESC)","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.leukres.2023.107351_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.736854","article-title":"Risk factors for anthracycline-induced cardiotoxicity","volume":"8","author":"Qiu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.leukres.2023.107351_bib6","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.leukres.2023.107351_bib7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJMcibr1214975","article-title":"Anthracyclines and heart failure","volume":"368","author":"Sawyer","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.leukres.2023.107351_bib8","first-page":"15","article-title":"Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: preventive strategies and treatment","volume":"11","author":"Cai","year":"2019","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.leukres.2023.107351_bib9","article-title":"Risk factors for anthracycline-induced cardiotoxicity in breast cancer treatment: a meta-analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2023.107351_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/1078155219873014","article-title":"Evaluation of cardiomyopathy in acute myeloid leukemia patients treated with anthracyclines","volume":"26","author":"Mort","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"7","key":"10.1016\/j.leukres.2023.107351_bib11","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/j.clml.2019.03.007","article-title":"Anthracycline-induced cardiotoxicity in acute myeloid leukemia patients who undergo allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Pasvolsky","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.leukres.2023.107351_bib12","unstructured":"G.M. Almuwaqqat Z., Schlafer D., et al., Incidence and predictors of left ventricular dysfunction among acute myeloid leukemia patients [abstract], In: Proceedings of the American Society of Hematology Annual Meeting. Abstract 5025., 2017."},{"issue":"3","key":"10.1016\/j.leukres.2023.107351_bib13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/annonc\/mdn776","article-title":"High risk of cardiac dysfunction after treatment of secondary acute myeloid leukaemia to breast cancer","volume":"20","author":"Willems","year":"2009","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2023.107351_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54669","article-title":"Association of anthracycline with heart failure in patients treated for breast cancer or lymphoma, 1985-2010","volume":"6","author":"Larsen","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"26","key":"10.1016\/j.leukres.2023.107351_bib15","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.leukres.2023.107351_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.leukres.2023.107351_bib17","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-022-33093-3","article-title":"Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease","volume":"13","author":"Uddin","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.leukres.2023.107351_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.121.037388","article-title":"Clonal hematopoiesis is associated with higher risk of stroke","volume":"53","author":"Bhattacharya","year":"2022","journal-title":"Stroke"},{"issue":"14","key":"10.1016\/j.leukres.2023.107351_bib19","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2021.02.028","article-title":"Clonal hematopoiesis and risk of progression of heart failure with reduced left ventricular ejection fraction","volume":"77","author":"Pascual-Figal","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107351_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2715","article-title":"Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers","volume":"25","author":"Shi","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.leukres.2023.107351_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol."},{"issue":"1","key":"10.1016\/j.leukres.2023.107351_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaccao.2021.11.008","article-title":"Cardiovascular disease among patients with AML and CHIP-related mutations","volume":"4","author":"Calvillo-Arg\u00fcelles","year":"2022","journal-title":"JACC CardioOncology"},{"key":"10.1016\/j.leukres.2023.107351_bib23","article-title":"Guidelines for survivors of childhood, adolescent and young adult","author":"Group","year":"2018","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.leukres.2023.107351_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jmoldx.2016.02.003","article-title":"Validation and implementation of a custom next-generation sequencing clinical assay for hematologic malignancies","volume":"18","author":"Kluk","year":"2016","journal-title":"J. Mol. Diagn."},{"issue":"22","key":"10.1016\/j.leukres.2023.107351_bib25","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"41","key":"10.1016\/j.leukres.2023.107351_bib26","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"issue":"13","key":"10.1016\/j.leukres.2023.107351_bib27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJMoa0904544","article-title":"Anthracycline dose intensification in acute myeloid leukemia","volume":"361","author":"Fernandez","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.leukres.2023.107351_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2006.06476.x","article-title":"The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia","volume":"136","author":"Giles","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.leukres.2023.107351_bib29","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107351_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-8722-7-25","article-title":"Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice","volume":"7","author":"Shi","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.leukres.2023.107351_bib31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMoa1611604","article-title":"Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation","volume":"376","author":"Lindsley","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.leukres.2023.107351_bib32","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41375-020-01043-x","article-title":"IDH1\/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis","volume":"35","author":"Kattih","year":"2021","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:04:21Z","timestamp":1758935061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623006161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":32,"alternative-id":["S0145212623006161"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107351","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107351"}}